While myofunctional therapy and playing the didgeridoo are known to improve snoring and mild obstructive sleep apnea, these options are not always practical or easily accessible to the millions of Americans with snoring and mild OSA.
Enter the new kid on the block @eXciteOSAwhich was FDA approved in February 2021.
How does it work? @exciteOSA is a retainer that fits around the tongue with two electrodes and the top and two on the bottom.
It is worn during the daytime for 20 minutes while neuromuscular stimulation is delivered to the tongue muscle. It is used daily for 6 weeks at increasing levels of stimulation and then twice a week thereafter.
What are the indications? @exciteOSA is indicated for snoring and mild OSA (AHI<15).
In clinical trials it showed an objective reduction in snoring in 95% of participants, an average snoring time reduction of 48%, AHI reduction of 52% (9.8 to 4.7), and ODI reduction by 48% (from 7.8 to 4.3).
@exciteOSA will is available with a prescription from a physician. Are you interested in seeing a demo on this new and exciting treatment for snoring and obstructive sleep apnea!